Imparare a tradurre dagli esempi di traduzione forniti da contributi umani.
Da traduttori professionisti, imprese, pagine web e archivi di traduzione disponibili gratuitamente al pubblico.
mitochondrial dysfunction following exposure in utero
mitokondriaalne düsfunktsioon pärast in utero kokkupuudet
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 1
Qualità:
therapy, increase the risk of malformations and death in utero.
loote väärarengute ja surma riski.
Ultimo aggiornamento 2011-10-23
Frequenza di utilizzo: 1
Qualità:
Attenzione: Questo allineamento potrebbe essere errato.
Eliminalo se ritieni che sia così.
exposure in utero to obinutuzumab and vaccination of infants with live virus vaccines
Üsasisene kokkupuude obinutuzumabiga ja imikute vaktsineerimine elusviirusvaktsiinidega
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 1
Qualità:
vaccine breakthrough infection (after in utero exposure to infliximab)*.
teadmata: vaktsiiniga seotud läbimurdeinfektsioon (pärast üsasisest kokkupuudet infliksimabiga)
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 1
Qualità:
rat offspring exposed to telaprevir in utero showed normal body weight at birth.
emakasiseselt telapreviiriga kokku puutunud rotiloodetel oli normaalne sünnikaal.
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 1
Qualità:
the safety of administering live vaccines to infants exposed to abatacept in utero is unknown.
elusvaktsiinide manustamise ohutus imikutele, kes on abatatseptile emakasisesi enne sündi eksponeeritud, on teadmata.
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 1
Qualità:
developmental toxicity studies performed in cynomolgus monkeys revealed no evidence of embryotoxicity in utero.
37 arengutoksilisuse uuringutes makaakidega ei ilmnenud in utero embrüotoksilisust.
Ultimo aggiornamento 2012-04-11
Frequenza di utilizzo: 4
Qualità:
in these studies, maternal antibodies to recombinant human hyaluronidase were transferred to offspring in utero.
nendes uuringutes manustati rekombinantse inimese hüaluronidaasi emapoolseid antikehasid järglasele emakasse.
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 1
Qualità:
not known: vaccine breakthrough infection (after in utero exposure to infliximab)*.
teadmata: vaktsiiniga seotud läbimurdeinfektsioon (pärast üsasisest kokkupuudet infliksimabiga).
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 1
Qualità:
any child exposed in utero to nucleoside and nucleotide analogues, even hiv-negative children, should
kõikidele lastele,
Ultimo aggiornamento 2011-10-23
Frequenza di utilizzo: 1
Qualità:
Attenzione: Questo allineamento potrebbe essere errato.
Eliminalo se ritieni che sia così.
additionally, developmental external or visceral abnormalities were identified in the urogenital system of 2 infants exposed in utero to ipilimumab.
lisaks sellele täheldati kahel in utero ipilimumabi ekspositsioonile allutatud vastsündinul urogenitaalsüsteemis väliseid või seesmisi väärarenguid.
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 1
Qualità:
dapagliflozin dosed to maternal rats from gestation day 6 through postnatal day 21, and pups were indirectly exposed in utero and throughout lactation.
emasloomadele annustati dapagliflosiini alates 6. gestatsioonipäevast kuni 21. postnataalse päevani ning pojad olid kaudselt eksponeeritud in utero ja imetamise ajal.
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 1
Qualità:
to care for and assist the mother during labour and to monitor the condition of the foetus in utero by the appropriate clinical and technical means;
hoolitseda ema eest sünnituse ajal ja teda abistada ning jälgida loote üsasisest seisundit asjakohaste kliiniliste ja tehniliste vahenditega;
administration of live vaccines to infants exposed to adalimumab in utero is not recommended for 5 months following the mother’s last adalimumab injection during pregnancy.
elusvaktsiinide manustamine vastsündinutele, kes olid emakas eksponeeritud adalimumabile, ei ole soovitatav viie kuu jooksul pärast emale manustatud viimast adalimumabi annust.
vertical, from mother to child, often in utero, or as a result of the incidental exchange of body fluids usually during the perinatal period,
vertikaalselt, emalt lapsele, sageli emaüsas või kehavedelike juhusliku vahetumise kaudu, tavaliselt sünnituseelsel perioodil;
there have been reports of mitochondrial dysfunction in hiv- negative infants exposed in utero and/or post-natally to nucleoside analogues.
mitokondriaalset düsfunktsiooni on kirjeldatud hiv-negatiivsetel imikutel, kes puutusid nukleosiidi analoogidega kokku in utero ja/või postnataalselt.
in case of in utero exposure, monitoring of the newborn for the potential adverse effects of tacrolimus is recommended (in particular the effects on the kidneys).
35 jälgida takroliimuse võimalike kõrvaltoimete suhtes (eriti toimet neerudele).
at least a six month waiting period following birth is recommended before the administration of live vaccines to infants exposed in utero to infliximab (see section 4.6).
enne üsasiseselt infliksimabiga kokkupuutunud imikutele elusvaktsiinide manustamist on soovitatav oodata vähemalt kuus kuud (vt lõik 4.6).
in a carcinogenicity study of rats exposed to 2,6-xylidine in utero, postnatally and throughout their lifetime, tumours in the nasal cavity, subcutaneous tumours and liver tumours were observed.
kartsinogeensuse uuringus rottidel, kes puutusid kokku 2,6-ksülidiiniga in utero, postnataalselt ja kogu elu jooksul, on täheldatud ninaõõne kasvajaid, subkutaanseid kasvajaid ja maksakasvajaid.
common: bleeding (gastrointestinal, haematuria, haematoma, epistaxis, haemoptysis, utero-vaginal haemorrhage, haemarthrosis, ocular, purpura, bruise)
pp